Search

everythinglearnresearchcommunity

for

Search:↓

Oral contraceptives with cyproterone acetate improved quality of life for women with PCOS more than those with levonorgestrel.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

Cabergoline is more effective and has fewer side effects than bromocriptine for treating women with hyperprolactinemic amenorrhea.

Most patients with PCOS were prescribed medroxyprogesterone acetate or oral contraceptives, with some experiencing side effects or needing prescription changes.

Progesterone-derived neurosteroids affect GABA-A receptor expression, influencing epilepsy during menstrual cycles.

Progesterone and related compounds may help control seizures linked to the menstrual cycle but have limitations that need addressing.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

Both LNG-IUD and systemic progestins are effective for fertility-sparing treatment, but close monitoring is needed due to recurrence risk.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Hormonal contraceptives may reduce social behavior and sexual motivation by lowering allopregnanolone levels.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

MPA improved hormonal imbalances and acne in women with PCOS without affecting metabolism.

Hormonal male contraception is effective and could be market-ready, but more research is needed to ensure safety for all ethnic groups.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

The hormonal contraceptive combination effectively reduces androgen excess and improves PCOS symptoms like acne, hair loss, and menstrual issues.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

Diane is effective for treating acne, seborrhoea, androgenic alopecia, and mild hirsutism in women.

Hormonal birth control can cause skin issues, but low-dose options and those with antiandrogens may reduce these effects.

Synthetic 19-norprogestins promote bone cell growth and function through their non-phenolic metabolites.

Oral contraceptives with CPA improve overall quality of life for women with PCOS.

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

Progesterone and its byproducts control a specific receptor in the brain independently of progesterone receptors, affecting conditions related to the menstrual cycle.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

Non-daily contraceptives cause fewer side effects and are more satisfying to women, and certain oral contraceptives can treat acne and seborrhoea, with a combination of chlormadinone acetate and ethinyl estradiol being highly effective and safe.

New progesterone-based compounds can block male hormones.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

Neogynon effectively prevents pregnancy but may cause side effects like headaches and menstrual changes.

Both finasteride and drospirenone treatments improved symptoms and increased pregnancy rates in women with polycystic ovary syndrome.